Fig. 2From: Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trialThe eGFR curves at different time points during the follow-up period in UC-MSCs and non-MSC groups. No significant difference in eGFR changes postoperatively between the two groups was found (P = 0.88)Back to article page